Veeva Summit 2025: Leaders Collaborate to Enhance Life Sciences Industry

Veeva Summit 2025: Strengthening the Future of Life Sciences

The Veeva R&D and Quality Summit, scheduled for September 3-4, 2025, in Boston, promises to be one of the most significant gatherings in the life sciences sector. This year's summit is set to feature prominent leaders from major biopharmaceutical companies, including Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi. Together, these industry giants will share their valuable insights, innovative strategies, and technological advancements aimed at transforming clinical, regulatory, safety, and quality processes.

Innovating with Technology

Central to the summit is Veeva's focus on technology integration. The company plans to showcase its latest software enhancements, specifically within the Vault Platform, which now incorporates Veeva AI. This advanced artificial intelligence system facilitates seamless access to critical data, documents, and workflows, enabling life sciences professionals to craft custom agents tailored to their unique operational needs. Attendees can look forward to over 100 sessions dedicated to the latest advancements in the field, fostering not only knowledge exchange but also inspiring new ideas and solutions.

Collaboration for Improvement

The summit will not only spotlight individual company innovations but also highlight collaborative initiatives designed to enhance efficiency across the sector. Merck, for instance, is leading efforts to unify operations and data management, thereby streamlining clinical processes with a singular pharmacovigilance platform. On a broader scale, FUJIFILM Biotechnologies is transitioning to a global quality management framework, which will significantly improve consistency and control across their operations.

BeOne Medicines will discuss how they're modernizing their regulatory submissions, increasing efficiency through submissions across multiple health authorities.

Moreover, attendees will learn how Immunovant has optimized trial oversight by providing real-time access to data from Contract Research Organizations (CROs), saving valuable time and significantly reducing the potential for errors.

Enhancing Engagement and Training

Another key feature of this year's summit is the focus on improving collaboration among various stakeholders involved in clinical trials. Sanofi, for example, will present its innovative solution aimed at streamlining study training by eliminating disjointed systems, thereby enhancing communication and efficiency among teams and site staff.

Memorial Sloan Kettering Cancer Center (MSK) will also share its insights on fostering better engagement with sponsors and CROs, focusing on the site perspective to improve trial outcomes.